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Introduction. Under current conditions, among the factors leading to perinatal and antenatal fetal 
death, the endocrinopathies of various origin, including hyperandrogenism (HA) become more 
important. During pregnancy the concentrations of human chorionic gonadotropin (HCG) and 
pregnancy-associated plasma protein-A (PAPP-A), can be indicative not only of some defects of fetal 
development but also of latent defects of implantation and formation of the placenta in the early period, 
which will be manifested in the second half of gestation with the following complications: arrest of fetal 
development, miscarriage to 22 weeks, preterm labor to 37 weeks, and gestosis. To diagnose the risks 
of arrest of the fetal development during first terms of pregnancy in women with low levels of PAPP-A 
was historically first clinical application to detect PAPP-A in the blood serum suggested at the beginning 
of 1980-s. 
Objective. To study a prognostic value of the concentrations of PAPP-A and HCG concerning the 
origin of the primary placental dysfunction in pregnant women with hyperandrogenism, to estimate the 
endocrine function of the placenta in these individuals as the basis in the diagnostics of pathological 
conditions of the intrauterine fetal state.  
Materials and methods. The core group (30 patients) - included pregnant women with hidden forms 
of HA. The control group consisted of 30 pregnant women without gestational complications. These are 
the results of the first biochemical screening. Pregnant women of "risk group" as to the placental 
dysfunction in 16-18, 20-24 weeks of gestation were examined for reproductive hormones, placental 
lactogen (PL), estriol (E3) and progesterone (PR) by standard methods. 
Results. In the statistical analysis of the results of the first biochemical screening, we noted that the 
level of HCG in the blood averaged 24198±0,5 mIU / ml in the study group, which is 36,7 % lower than 
the same index in the control group. The level of PAPP-A in the serum of pregnant women with 
hyperandrogenism was 1960±0,9 mIU /ml, which is 45,8% less than in the control group.  
We have established that in pregnant women "at risk" on the origin of placental dysfunction, mean 
values of reproductive hormones were significantly lower during their whole pregnancy. PR level in 16-
18 weeks was 34,58±0,48 nmol/L in 20-24 weeks - 72,16±3,67; (p<0.0001). The most significant 
difference between the groups of PL (more than 3-fold ) occurred at 20-24 weeks (control group - 
3,48±0,04 mg/l, the main group - 1,13±0,02 mg/l; p<0.0001), and estriol concentration after 20-24 
weeks of gestation it was 3 times lower - 28,06±0,39 nmol/L than in the control group (p < 0.0001). 
Conclusion. Based on the results of the first biochemical screening in pregnant women with 
hyperandrogenism we can detect the risk of a number of pregnancy complications (not just defects) that 
can help in developing an individual program of pregnancy.  
 
 
